169 related articles for article (PubMed ID: 38786112)
1. Association between Empirical Anti-Pseudomonal Antibiotics and Progression to Thoracic Surgery and Death in Empyema: Database Research.
Shiroshita A; Tochitani K; Maki Y; Terayama T; Kataoka Y
Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786112
[TBL] [Abstract][Full Text] [Related]
2. Association Between Empirical Anti-Pseudomonal Antibiotics for Recurrent Lower Respiratory Tract Infections and Mortality: A Retrospective Cohort Study.
Shiroshita A; Yamamoto S; Anan K; Suzuki H; Takeshita M; Kataoka Y
Int J Chron Obstruct Pulmon Dis; 2022; 17():2919-2929. PubMed ID: 36419949
[TBL] [Abstract][Full Text] [Related]
3. Systemic antibiotics for treating diabetic foot infections.
Selva Olid A; Solà I; Barajas-Nava LA; Gianneo OD; Bonfill Cosp X; Lipsky BA
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009061. PubMed ID: 26337865
[TBL] [Abstract][Full Text] [Related]
4. Oral anti-pseudomonal antibiotics for cystic fibrosis.
Remmington T; Jahnke N; Harkensee C
Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study.
Shiroshita A; Miyakoshi C; Tsutsumi S; Shiba H; Shirakawa C; Sato K; Matsushita S; Kimura Y; Tomii K; Ohgiya M; Kataoka Y
Sci Rep; 2021 Oct; 11(1):20066. PubMed ID: 34625632
[TBL] [Abstract][Full Text] [Related]
6. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
Ryan G; Mukhopadhyay S; Singh M
Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732
[TBL] [Abstract][Full Text] [Related]
7. Oral anti-pseudomonal antibiotics for cystic fibrosis.
Remmington T; Jahnke N; Harkensee C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
[TBL] [Abstract][Full Text] [Related]
8. Oral anti-pseudomonal antibiotics for cystic fibrosis.
Remmington T; Jahnke N; Harkensee C
Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
[TBL] [Abstract][Full Text] [Related]
9. Surgical versus non-surgical management for pleural empyema.
Redden MD; Chin TY; van Driel ML
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Ceftriaxone plus Metronidazole versus Anti-Pseudomonal Antibiotics for Perforated Appendicitis in Children.
Hamdy RF; Handy LK; Spyridakis E; Dona D; Bryan M; Collins JL; Gerber JS
Surg Infect (Larchmt); 2019 Jul; 20(5):399-405. PubMed ID: 30874482
[No Abstract] [Full Text] [Related]
11. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
Ryan G; Mukhopadhyay S; Singh M
Cochrane Database Syst Rev; 2003; (3):CD001021. PubMed ID: 12917897
[TBL] [Abstract][Full Text] [Related]
12. Posttraumatic empyema thoracis: a 24-year experience at a major trauma center.
Mandal AK; Thadepalli H; Mandal AK; Chettipalli U
J Trauma; 1997 Nov; 43(5):764-71. PubMed ID: 9390487
[TBL] [Abstract][Full Text] [Related]
13. Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial.
Qian ET; Wang L; Stollings JL; Casey JD; Rice TW; Semler MW
J Intensive Care Med; 2023 Dec; 38(12):1127-1135. PubMed ID: 37357717
[No Abstract] [Full Text] [Related]
14. [Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].
Cuesta DP; Blanco VM; Vallejo ME; Hernández-Gómez C; Maya JJ; Motoa G; Correa A; Matta L; Rosso F; Camargo RD; Muñoz M; Florez E; Nagles J; Ovalle A; Reyes S; Villegas MV
Rev Chilena Infectol; 2019 Feb; 36(1):9-15. PubMed ID: 31095199
[TBL] [Abstract][Full Text] [Related]
15. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
16. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.
Zobell JT; Young DC; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
Pediatr Pulmonol; 2013 Jun; 48(6):525-37. PubMed ID: 23359557
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of medically and surgically treated empyema patients: a retrospective cohort study.
Dusemund F; Weber MD; Nagel W; Schneider T; Brutsche MH; Schoch OD
Respiration; 2013; 86(4):288-94. PubMed ID: 23988906
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
19. Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema.
Avner BS; Ginosyan A; Le J; Mak J; Qiryaqoz Z; Huffman C
BMC Infect Dis; 2022 Oct; 22(1):783. PubMed ID: 36224539
[TBL] [Abstract][Full Text] [Related]
20. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Holland P; Jahnke N
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
